259 related articles for article (PubMed ID: 21789919)
1. [Counterfeit drugs as a gobal threat to health].
Golocorbin Kon S; Mikov M
Med Pregl; 2011; 64(5-6):285-90. PubMed ID: 21789919
[TBL] [Abstract][Full Text] [Related]
2. [Counterfeit medicines: a growing threat].
Barbereau S
Med Trop (Mars); 2006 Dec; 66(6):529-32. PubMed ID: 17286014
[TBL] [Abstract][Full Text] [Related]
3. [Counterfeit medicines--Japan and the world].
Sato D
Yakugaku Zasshi; 2014; 134(2):213-22. PubMed ID: 24492225
[TBL] [Abstract][Full Text] [Related]
4. [Anti-counterfeit activities of pharmaceutical companies in Japan: for patient safety].
Shofuda K; Aragane K; Igari Y; Matsumoto K; Ito K
Yakugaku Zasshi; 2014; 134(2):203-11. PubMed ID: 24492224
[TBL] [Abstract][Full Text] [Related]
5. Perceptions and practices of pharmaceutical wholesalers surrounding counterfeit medicines in a developing country: a baseline survey.
Khan MH; Akazawa M; Dararath E; Kiet HB; Sovannarith T; Nivanna N; Yoshida N; Kimura K
BMC Health Serv Res; 2011 Nov; 11():306. PubMed ID: 22074046
[TBL] [Abstract][Full Text] [Related]
6. Problems associated with substandard and counterfeit drugs in developing countries: a review article on global implications of counterfeit drugs in the era of antiretroviral (ARVs) drugs in a free market economy.
Nsimba SE
East Afr J Public Health; 2008 Dec; 5(3):205-10. PubMed ID: 19374325
[TBL] [Abstract][Full Text] [Related]
7. Roles for pharmacy in combatting counterfeit drugs.
Ziance RJ
J Am Pharm Assoc (2003); 2008; 48(4):e71-88; quiz e89-91. PubMed ID: 18653407
[TBL] [Abstract][Full Text] [Related]
8. Assessing the problem of counterfeit medications in the United Kingdom.
Jackson G; Patel S; Khan S
Int J Clin Pract; 2012 Mar; 66(3):241-50. PubMed ID: 22070229
[TBL] [Abstract][Full Text] [Related]
9. Fighting trafficking of falsified and substandard medicinal products in Russia.
Fayzrakhmanov NF
Int J Risk Saf Med; 2015; 27 Suppl 1():S37-40. PubMed ID: 26639702
[TBL] [Abstract][Full Text] [Related]
10. [The role of German official medicines control laboratories in combating counterfeit medicines].
Wiegard A; Heuermann M
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 Nov; 60(11):1214-1220. PubMed ID: 28948293
[TBL] [Abstract][Full Text] [Related]
11. [Counterfeit and Falsified Drugs: an Overview].
Taverriti-Fortier C; Pape E; Scala-Bertola J; Tréchot P; Maincent P; Gibaja V; Gambier N
Therapie; 2015; 70(5):455-64. PubMed ID: 26071144
[TBL] [Abstract][Full Text] [Related]
12. Substandard and counterfeit antimicrobials: recent trends and implications to key public health interventions in developing countries.
Tadeg H; Berhane Y
East Afr J Public Health; 2012 Jun; 9(2):85-9. PubMed ID: 23139963
[TBL] [Abstract][Full Text] [Related]
13. Health risks of counterfeit pharmaceuticals.
ten Ham M
Drug Saf; 2003; 26(14):991-7. PubMed ID: 14583061
[TBL] [Abstract][Full Text] [Related]
14. Counterfeit pharmaceuticals: current status and future projections.
Wertheimer AI; Chaney NM; Santella T
J Am Pharm Assoc (2003); 2003; 43(6):710-7; quiz 717-8. PubMed ID: 14717268
[TBL] [Abstract][Full Text] [Related]
15. Update on counterfeit antibiotics worldwide; public health risks.
Delepierre A; Gayot A; Carpentier A
Med Mal Infect; 2012 Jun; 42(6):247-55. PubMed ID: 22621827
[TBL] [Abstract][Full Text] [Related]
16. Counterfeit drugs and medical devices in developing countries.
Glass BD
Res Rep Trop Med; 2014; 5():11-22. PubMed ID: 32669888
[TBL] [Abstract][Full Text] [Related]
17. Public health interventions to protect against falsified medicines: a systematic review of international, national and local policies.
Hamilton WL; Doyle C; Halliwell-Ewen M; Lambert G
Health Policy Plan; 2016 Dec; 31(10):1448-1466. PubMed ID: 27311827
[TBL] [Abstract][Full Text] [Related]
18. Legal aspects of counteracting the trafficking of falsified medicines in the european union.
Pashkov V; Soloviov A; Olefir A
Wiad Lek; 2017; 70(4):843-849. PubMed ID: 29064815
[TBL] [Abstract][Full Text] [Related]
19. [The fight against counterfeit medicines in Africa: experience and role of pharmacists].
Chauvé M
C R Biol; 2008 Dec; 331(12):982-5. PubMed ID: 19027699
[TBL] [Abstract][Full Text] [Related]
20. [Counterfeit and contraband drugs in Brazil: overview and prospects for preventing their use].
Hurtado RL; Lasmar MC
Cad Saude Publica; 2014 Apr; 30(4):891-5. PubMed ID: 24896066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]